These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6831050)

  • 1. Anticonvulsant-induced aplastic anemia: increased susceptibility to toxic drug metabolites in vitro.
    Gerson WT; Fine DG; Spielberg SP; Sensenbrenner LL
    Blood; 1983 May; 61(5):889-93. PubMed ID: 6831050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predisposition to phenytoin hepatotoxicity assessed in vitro.
    Spielberg SP; Gordon GB; Blake DA; Goldstein DA; Herlong HF
    N Engl J Med; 1981 Sep; 305(13):722-7. PubMed ID: 6790991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial occurrence of hypersensitivity to phenytoin.
    Gennis MA; Vemuri R; Burns EA; Hill JV; Miller MA; Spielberg SP
    Am J Med; 1991 Dec; 91(6):631-4. PubMed ID: 1750433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk.
    Shear NH; Spielberg SP
    J Clin Invest; 1988 Dec; 82(6):1826-32. PubMed ID: 3198757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aromatic antiepileptic drugs and mitochondrial toxicity: effects on mitochondria isolated from rat liver.
    Santos NA; Medina WS; Martins NM; Mingatto FE; Curti C; Santos AC
    Toxicol In Vitro; 2008 Aug; 22(5):1143-52. PubMed ID: 18434079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An in vitro study of the microsomal metabolism and cellular toxicity of phenytoin, sorbinil and mianserin.
    Riley RJ; Maggs JL; Lambert C; Kitteringham NR; Park BK
    Br J Clin Pharmacol; 1988 Nov; 26(5):577-88. PubMed ID: 3207562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of phenytoin and carbamazepine in treatment of epilepsy.
    Ramsay RE
    Neurol Clin; 1986 Aug; 4(3):585-600. PubMed ID: 2943977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematologic toxicity of carbamazepine.
    Pisciotta AV
    Adv Neurol; 1975; 11():355-68. PubMed ID: 1217569
    [No Abstract]   [Full Text] [Related]  

  • 9. Phenytoin and carbamazepine, alone and in combination: anticonvulsant and neurotoxic effects.
    Morris JC; Dodson WE; Hatlelid JM; Ferrendelli JA
    Neurology; 1987 Jul; 37(7):1111-8. PubMed ID: 3601077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro assessment of a hypersensitivity syndrome associated with sorbinil.
    Spielberg SP; Shear NH; Cannon M; Hutson NJ; Gunderson K
    Ann Intern Med; 1991 May; 114(9):720-4. PubMed ID: 2012352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal aplastic anemia in a patient treated with carbamazepine.
    Franceschi M; Ciboddo G; Truci G; Borri A; Canal N
    Epilepsia; 1988; 29(5):582-3. PubMed ID: 3409843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug hypersensitivity to previously tolerated phenytoin by carbamazepine-induced DRESS syndrome.
    Kim CW; Choi GS; Yun CH; Kim DI
    J Korean Med Sci; 2006 Aug; 21(4):768-72. PubMed ID: 16891830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbamazepine-induced hemolytic and aplastic crises associated with reduced glutathione peroxidase activity of erythrocytes.
    Yamamoto M; Suzuki N; Hatakeyama N; Kubo N; Tachi N; Kanno H; Fujii H; Tsutsumi H
    Int J Hematol; 2007 Nov; 86(4):325-8. PubMed ID: 18055338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the microsomal epoxide hydrolase gene in patients with anticonvulsant adverse drug reactions.
    Gaedigk A; Spielberg SP; Grant DM
    Pharmacogenetics; 1994 Jun; 4(3):142-53. PubMed ID: 7920694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbamazepine-hypersensitivity: assessment of clinical and in vitro chemical cross-reactivity with phenytoin and oxcarbazepine.
    Pirmohamed M; Graham A; Roberts P; Smith D; Chadwick D; Breckenridge AM; Park BK
    Br J Clin Pharmacol; 1991 Dec; 32(6):741-9. PubMed ID: 1768568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro assessment of pharmacogenetic susceptibility to toxic drug metabolites in humans.
    Spielberg SP
    Fed Proc; 1984 May; 43(8):2308-13. PubMed ID: 6714438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute respiratory failure mediated by reactive drug metabolites.
    Murphy D; Kronick JB; Rieder MJ
    Biol Neonate; 1995; 67(4):223-9. PubMed ID: 7647145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nafimidone, an imidazole anticonvulsant, and its metabolite as potent inhibitors of microsomal metabolism of phenytoin and carbamazepine.
    Kapetanovic IM; Kupferberg HJ
    Drug Metab Dispos; 1984; 12(5):560-4. PubMed ID: 6149905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of cytochrome P450-mediated metabolism and involvement of reactive metabolite formations on antiepileptic drug-induced liver injuries.
    Sasaki E; Yokoi T
    J Toxicol Sci; 2018; 43(2):75-87. PubMed ID: 29479037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Aplastic anemia in carbamazepine therapy].
    Betticher DC; Wolfisberg HP; Krapf R
    Schweiz Med Wochenschr; 1991 Apr; 121(16):583-8. PubMed ID: 2042043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.